Oramed Pharmaceuticals (ORMP) Q1 2026 Earnings
ORMP·Reported May 19, 2026·After market close
Diluted EPS came in at $-0.16 (+15.8% YoY).
Diluted EPS
$-0.16
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Oramed Pharmaceuticals's Q1 2026 earnings report.
Oramed Pharmaceuticals (ORMP) reported Q1 2026 earnings on May 19, 2026 after market close.
Oramed Pharmaceuticals reported diluted EPS of $-0.16 for Q1 2026.
Compared to the same quarter a year prior, diluted EPS grew 15.8% from $-0.19.
You can read the 10-Q periodic report (0001213900-26-059112) directly on SEC EDGAR. The filing index links above go to sec.gov.